Authors
Loading...
May support myostatin targeting in HF-related sarcopenia; leaves open definitive cardiovascular trials.
Key points are not available for this paper at this time.
Se‐Jin Lee (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: